Destrin

From WikiMD's WELLNESSPEDIA

File:Destrin.png
Illustration of the Destrin protein structure

Destrin, also known as actin-depolymerizing factor (ADF), is a protein that plays a crucial role in the regulation of the actin cytoskeleton in eukaryotic cells. It is involved in the disassembly of actin filaments, which is essential for various cellular processes such as cell motility, cytokinesis, and cellular morphogenesis.

Structure[edit]

Destrin is a member of the ADF/cofilin family of proteins, which are characterized by their ability to bind to actin and modulate its dynamics. The protein consists of a single polypeptide chain that folds into a compact structure, allowing it to interact with actin filaments. The structure of destrin includes several key regions that are responsible for its actin-binding and depolymerizing activities.

Function[edit]

Destrin functions primarily by binding to ADP-bound actin filaments, promoting their disassembly. This activity is crucial for the turnover and remodeling of the actin cytoskeleton, which is necessary for cell movement and shape changes. Destrin's ability to sever actin filaments and increase the rate of actin monomer dissociation is vital for maintaining the dynamic nature of the cytoskeleton.

Regulation[edit]

The activity of destrin is regulated by several factors, including phosphorylation and interactions with other proteins. Phosphorylation of destrin can inhibit its actin-depolymerizing activity, thereby stabilizing actin filaments. Additionally, destrin can be regulated by phosphoinositides and other signaling molecules that modulate its interaction with actin.

Clinical Significance[edit]

Alterations in destrin function or expression have been implicated in various diseases. For example, dysregulation of actin dynamics due to abnormal destrin activity can contribute to cancer cell metastasis, as well as neurodegenerative diseases. Understanding the role of destrin in these conditions may provide insights into potential therapeutic targets.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Destrin&oldid=6625460"